RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $125
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice Target
RBC Capital analyst Kendall Au maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $110 to $125.
RBC Capital analyst Kendall Au maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $110 to $125.